secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001437749-24-012736
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 4.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key restates FY2023 quarterly financials due to revenue recognition errors; receives Nasdaq non-compliance notice
--------------------------------------------------------------------------------

- Audit committee found errors in revenue recognition at Swivel Secure Europe for Q1-Q3 2023.
- Previously issued financials for Q1, Q2, Q3 2023 and related press releases no longer reliable.
- Revenue overstated, accounts receivable overstated; allowances and reserves understated; net loss understated.
- Nasdaq notice for late 10-K filing; 60 days to submit plan, extension possible to Oct 14, 2024.
- Company plans to file restated financials and annual report as soon as practicable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924012736/0001437749-24-012736-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924012736/bkyi20240422_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-012736

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer